An interventional study of Wavelight Plus Alcon system and SMILE in Myopia, sponsored by Beijing Visionly Plus Eye Hospital. Recruiting at 2 sites in China. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2025-01-23.
Sponsored by Beijing Visionly Plus Eye Hospital · Not applicable, Interventional, and Treatment
Myopia is a prevalent refractive error with significant lifestyle impact. While traditional SMILE (Small Incision Lenticule Extraction) and ICL (Implantable Collamer Lens) surgeries are standard options, the advent of the Wavelight Plus Alcon system presents a promising new technique. This trial aims to evaluate the safety, efficacy, and patient satisfaction across these methods.
984 studies on the registry are indexed under Myopia; 210 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 80 across 783 interventional studies indexed under Myopia.
Browse Myopia studies →Beijing Visionly Plus Eye Hospital is the lead sponsor of 3 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Standard Small Incision Lenticule Extraction (SMILE) procedure using VisuMax laser
Procedure: SMILE
Implantable Collamer Lens (ICL) implantation using the STAAR Surgical Visian ICL
Procedure: ICL
Laser vision correction using the Wavelight Plus Alcon system
Procedure: Wavelight Plus Alcon system
Wavelight Plus Alcon system guided surgery for myopia
Also known as: Small Incision Lenticule Extraction, Implantable Collamer Lens
Small Incision Lenticule Extraction surgery for myopia
Implantable Collamer Lens surgery for myopia
Vision at 12 months post-surgery
Uncorrected distance vision (UDVA) at 12 months post-surgery
Time frame: From the day of surgery through to the 12-month post-operative follow-up
Change in spherical equivalent at 12 months post-surgery
Change of the spherical equivalent at 12 months post-surgery
Time frame: From the day of surgery through to the 12-month post-operative follow-up
Plan to share: Yes — Only IPD used in the results publication will be shared
Supporting information: Study protocol, Sap, Icf, Csr, Analytic code
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Beijing Visionly Plus Eye Hospital